The altered transit actually disrupts the carefully timed handoff between R-binder in the stomach and intrinsic factor in the duodenum
But the efficacy varies widely among patients, likely depending on the timing and intensity of the intervention, patient age, and family economics, as well as genetic or other fixed factors that contribute to obesity (1)
Int J Mol Sci 11(11):44654487
M., Merchant, C
Description Cagrilintide 5mg Research-Grade Compound Cagrilintide 5mg is a research-grade compound supplied in a sterile vial, intended for use in controlled laboratory settings
results seen within 3-6 weeks Post-Treatment Care: Hydration, avoiding sun, no heavy makeup, no swimming for 3 days, low-fat diet, increased water intake Safety: Not suitable for pregnant or breastfeeding women, or those with liver/kidney issues